Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#183 of 589

Julian Harrison

BTIG · Equity Research Analyst
ProvisionalRating since 2023No new ratings since Nov 2025

Analyst rating accuracy & track record

Julian Harrison is an equity research analyst at BTIG. Quantellect has scored 39 of their stock calls across 21 companies. Their picks beat their sector 41% of the time over the next 12 months, and their price targets were reached 43% of the time within a year.

Win % vs sector
41%
PT Hit % (12mo)
43%
Avg sector-excess
−0.5%
Scored calls
39
Tickers
21
Tier
Provisional

Track record

Quantellect has scored 39 of Julian Harrison's stock calls across 21 companies, dating back to 2023. Their rated stocks beat their own sector 41% of the time over the next 12 months. On a typical call, a Harrison pick returned −0.5% more than its sector over the following year.

Of the scored calls, 39 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
CNTBConnect Biopharma Holdings Ltd
Buy$10.00Nov 2025−93.5%Miss
VRDNViridian Therapeutics Inc
Buy$61.00Nov 2025−12.3%Miss
LQDALiquidia Technologies Inc
Buy$49.00Nov 2025+48.0%Hit
VRDNViridian Therapeutics Inc
Buy$61.00Nov 2025−12.3%Miss
VRDNViridian Therapeutics Inc
Buy$61.00Nov 2025−12.3%Miss
PTGXProtagonist Therapeutics Inc
Buy$82.00Nov 2025+55.4%Hit
PTGXProtagonist Therapeutics Inc
Buy$82.00Nov 2025+55.4%Hit
CNTBConnect Biopharma Holdings Ltd
Buy$10.00Oct 2025−81.8%Miss
AKBAAkebia Ther
Buy$5.00Oct 2025−93.3%Miss
PTGXProtagonist Therapeutics Inc
Buy$82.00Oct 2025+59.5%Hit
CLYMClimb Bio Inc
Buy$8.00Oct 2025+384.4%Hit
TVRDTvardi Therapeutics, Inc.
Buy$15.00Oct 2025−105.3%Miss
JBIOJade Biosciences, Inc.
Buy$28.00Oct 2025+37.3%Hit
ABVXAbivax SA American Depositary Shares
Buy$120.00Oct 2025−17.2%Hit
CLYMClimb Bio Inc
Buy$8.00Sep 2025+463.9%Hit
AVTXAvalo Therapeutics Inc
Buy$40.00Sep 2025−1.1%Miss
NKTRNektar Therapeutics
Buy$100.00Sep 2025−11.2%Hit
RZLTRezolute Inc
Buy$17.00Sep 2025−73.9%Miss
SYRESpyre Therapeutics Inc.
Buy$70.00Sep 2025+482.4%Hit
MAZEMaze Therapeutics, Inc. Common Stock
Buy$37.00Sep 2025−18.0%Hit
MAZEMaze Therapeutics, Inc. Common Stock
Buy$37.00Sep 2025−15.7%Hit
CGEMCullinan Oncology LLC
Buy$32.00Sep 2025+197.1%Miss
ABVXAbivax SA American Depositary Shares
Buy$112.00Sep 2025+13.4%Hit
MAZEMaze Therapeutics, Inc. Common Stock
Buy$30.00Sep 2025+47.9%Hit
TBPHTheravance Biopharma Inc
Buy$25.00Jun 2025+33.9%Miss
Prev1
Go to

Julian Harrison: analyst track record FAQ

Is Julian Harrison a good stock analyst?

Yes, by track record. Julian Harrison ranks number 183 of 589 of the analysts Quantellect scores, with an Analyst Score of 49 out of 100. Past results do not guarantee future ones.

What is Julian Harrison's win rate?

Julian Harrison's win rate is 41%. Across 39 scored calls, their rated stocks beat their sector 41% of the time over the next 12 months. On a typical call they returned −0.5% more than the sector.

What stocks and sectors does Julian Harrison cover?

Julian Harrison covers 21 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Julian Harrison's price targets accurate?

Julian Harrison's price targets are reached within 12 months 43% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Julian Harrison's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Julian Harrison rank among Wall Street analysts?

Julian Harrison ranks number 183 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.